Hongda Ding

No. 36 Sanhao Road
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

AARS1-mediated lactylation reprograms macrophage lipid metabolism to restrict antitumor immunity.

AARS1-mediated lactylation reprograms macrophage lipid metabolism to restrict antitumor immunity.

Journal: Journal for immunotherapy of cancer

Published: August 04, 2026

IL-2(N88D)/CD25 Fusion Protein Enhances Expansion of Antigen-Specific CD8⁺ T Cells to Suppress Hepatocellular Carcinoma.

IL-2(N88D)/CD25 Fusion Protein Enhances Expansion of Antigen-Specific CD8⁺ T Cells to Suppress Hepatocellular Carcinoma.

Journal: Communications biology

Published: November 24, 2025

MSR1 + macrophages passivate antitumor immunity by inducing ITM2A + CD4T exhaustion differentiation.

MSR1 + macrophages passivate antitumor immunity by inducing ITM2A + CD4T exhaustion differentiation.

Journal: Hepatology (Baltimore, Md.)

Published: June 02, 2025

Investigating intra-tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single-cell RNA sequencing.

Investigating intra-tumoural heterogeneity and microenvironment diversity in primary cardiac angiosarcoma through single-cell RNA sequencing.

Journal: Clinical and translational medicine

Published: June 08, 2024

Retraction Note: Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.

Retraction Note: Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 15, 2023

Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.

Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.

Journal: Frontiers in immunology

Published: May 30, 2022

Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA.

Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA.

Journal: Cellular and molecular gastroenterology and hepatology

Published: July 16, 2020

NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA.

NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA.

Journal: Cancer cell international

Published: June 18, 2020

What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis.

What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis.

Journal: Pharmacological research

Published: January 21, 2020

GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.

GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.

Journal: Cellular & molecular biology letters

Published: October 09, 2019

Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.

Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 27, 2019

Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.

Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.

Journal: Biochemical and biophysical research communications

Published: April 19, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026